RNA Vaccines
Editat de Thomas Kramps, Knut Elbersen Limba Engleză Paperback – 7 iul 2018
Authoritative and cutting-edge, RNA Vaccines: Methods and Protocols aims to increased collaboration on RNA vaccines between basic and applied scientists in academia, government, and industry to develop future solutions for today’s challenges.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 746.83 lei 6-8 săpt. | |
| Humana – 7 iul 2018 | 746.83 lei 6-8 săpt. | |
| Hardback (1) | 1124.50 lei 6-8 săpt. | |
| Springer – 17 dec 2016 | 1124.50 lei 6-8 săpt. |
Preț: 746.83 lei
Preț vechi: 786.14 lei
-5%
Puncte Express: 1120
Preț estimativ în valută:
131.98€ • 152.53$ • 114.39£
131.98€ • 152.53$ • 114.39£
Carte tipărită la comandă
Livrare economică 22 aprilie-06 mai
Specificații
ISBN-13: 9781493982141
ISBN-10: 1493982141
Pagini: 296
Ilustrații: XI, 282 p. 42 illus., 26 illus. in color.
Dimensiuni: 178 x 254 x 17 mm
Greutate: 0.56 kg
Ediția:Softcover reprint of the original 1st edition 2017
Editura: Humana
Locul publicării:New York, NY, United States
ISBN-10: 1493982141
Pagini: 296
Ilustrații: XI, 282 p. 42 illus., 26 illus. in color.
Dimensiuni: 178 x 254 x 17 mm
Greutate: 0.56 kg
Ediția:Softcover reprint of the original 1st edition 2017
Editura: Humana
Locul publicării:New York, NY, United States
Cuprins
Introduction to RNA Vaccines.- Self-replicating RNA.- Self-replicating RNA Vaccine Delivery to Dendritic Cells.- Plant Expression of Trans-encapsidated Viral Nanoparticle Vaccines with Animal RNA Replicons.- RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA Vaccines.- Nucleoside Modified mRNA Vaccines for Infectious Diseases.- Generation and Evaluation of Prophylactic mRNA Vaccines against Allergy.- Measuring the Adjuvant Activity of RNA Vaccines.- Generation of Immunostimulating 130 nm Protamine-RNA Nanoparticles.- Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.- Adjuvant-Enhanced mRNA Vaccines.- Enhanced Delivery of DNA or RNA Vaccines by Electroporation.- The European Regulatory Environment of RNA-Based Vaccines.- Discovery and Subtyping of Neo-Epitope Specific T-cell Responses for Cancer Immunotherapy: Addressing the Mutanome.- Considerations for Producing mRNA Vaccines for Clinical Trials.- Nonclinical Safety Testing of RNA Vaccines.- Immunotherapy of Uveal Melanoma: Vaccination Against Cancer.
Caracteristici
Includes cutting-edge methods and protocols Provides step-by-step detail essential for reproducible results Contains key notes and implementation advice from the experts Includes supplementary material: sn.pub/extras